---
document_datetime: 2025-11-23 07:07:24
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/medicines/human/EPAR/destara.html
document_name: destara.html
version: success
processing_time: 0.0432223
conversion_datetime: 2025-12-28 10:20:31.774842
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
# Destara

[RSS](/en/individual-human-medicine.xml/66612)

##### Withdrawn

This medicine's authorisation has been withdrawn

ibandronic acid

Medicine

Human

Withdrawn

Page contents

## Page contents

- [Overview](#overview)
- [Product information](#product-info)
- [Product details](#product-details)
- [Authorisation details](#authorisation-details)

- Application under evaluation
- CHMP opinion
- European Commission decision

## Overview

The marketing authorisation for Destara has been withdrawn at the request of the marketing authorisation holder.

## Product information

31/12/2009

icon globe

<!-- image -->

This medicine's product information is available in all **official EU languages** . Select 'available languages' to access the language you need.

Product information documents contain:

- summary of product characteristics (annex I);
- manufacturing authorisation holder responsible for batch release (annex IIA);
- conditions of the marketing authorisation (annex IIB);
- labelling (annex IIIA);
- package leaflet (annex IIIB).

## Product details

Name of medicine Destara Active substance ibandronic acid International non-proprietary name (INN) or common name ibandronic acid Therapeutic area (MeSH)

- Hypercalcemia
- Cancer

Anatomical therapeutic chemical (ATC) code M05BA06

### Pharmacotherapeutic group

Drugs for treatment of bone diseases

### Therapeutic indication

Treatment of tumour-induced hypercalcaemia with or without metastases.

## Authorisation details

EMA product number EMEA/H/C/000103 Marketing authorisation holder

Roche Registration Ltd.

6 Falcon Way Shire Park Welwyn Garden City AL7 1TW United Kingdom

Marketing authorisation issued 25/06/1996

**This page was last updated on** 31/12/2009

## Share this page

[Back to top](#main-content)